Skip to main content

United States News All stories

Every story in this section, newest first — page 223 of 373.

Grafa
Technology

Raytheon successfully flight tests RAIVEN staring sensor suite on UH-60 Black Hawk

Raytheon, an RTX (NYSE:RTX) business, achieved a major milestone in its next-generation sensing portfolio on April 15, 2026, with the successful completion of the first flight test of the RAIVEN Staring sensing system.

Read more: Raytheon successfully flight tests RAIVEN staring sensor suite on UH-60 Black Hawk
Grafa

60 Degrees Pharmaceuticals expands ARAKODA access via Runway Health telehealth partnership

60 Degrees Pharmaceuticals (NASDAQ:SXTP) announced on April 15, 2026, a strategic partnership with Runway Health to make ARAKODA (tafenoquine) available to U.S. travelers via a dedicated telehealth platform.

Read more: 60 Degrees Pharmaceuticals expands ARAKODA access via Runway Health telehealth partnership
Grafa

Immutep receives FDA orphan drug designation for eftilagimod alfa in soft tissue sarcoma

Immutep (NASDAQ:IMMP), a clinical-stage biotechnology company developing LAG-3 immunotherapies, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead product candidate, eftilagimod alfa (efti), for the treatment of soft tissue sarcoma (STS).

Read more: Immutep receives FDA orphan drug designation for eftilagimod alfa in soft tissue sarcoma
Grafa
Health

Arbutus Biopharma receives FDA fast track designation for HBV candidate imdusiran

Arbutus Biopharma (NASDAQ:ABUS), a clinical-stage biopharmaceutical company specializing in chronic infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for imdusiran (AB-729) for the treatment of chronic hepatitis B (cHBV).

Read more: Arbutus Biopharma receives FDA fast track designation for HBV candidate imdusiran
Grafa

Aurora Cannabis expands global footprint with $26.5M acquisition of Safari Flower

Aurora Cannabis (NASDAQ:ACB) has announced the acquisition of Safari Flower Company for a total consideration of $26.5 million, a strategic move designed to significantly expand its European Union Good Manufacturing Practice (EU GMP) cultivation and manufacturing capacity.

Read more: Aurora Cannabis expands global footprint with $26.5M acquisition of Safari Flower
Grafa
Retail

Vince Holding sales climb 4.7% as direct-to-consumer growth offsets wholesale weakness

Vince Holding (NASDAQ:VNCE) reported financial results for the fourth quarter and fiscal year ended January 31, 2026, revealing a complex performance marked by top-line growth and significant one-time headwinds.

Read more: Vince Holding sales climb 4.7% as direct-to-consumer growth offsets wholesale weakness
Grafa

ARS Pharmaceuticals secures health Canada approval for needle-free epinephrine

ARS Pharmaceuticals (NASDAQ:SPRY) has received Health Canada approval for neffy 2 mg, marking the first time a needle-free epinephrine delivery system has been authorized for the emergency treatment of severe allergic reactions in Canada.

Read more: ARS Pharmaceuticals secures health Canada approval for needle-free epinephrine